Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K3WN
|
||||
| Former ID |
DIB015446
|
||||
| Drug Name |
DNP-004089
|
||||
| Synonyms |
BACE inhibitors, De Novo; DNP-004089; Beta-amyloid converting enzyme inhibitors,De Novo; Beta-secretase inhibitors, De Novo
|
||||
| Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Terminated | [1] | ||
| Company |
De Novo Pharmaceuticals Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
S(=O)(=O)(N([C@H](C(=O)N[C@H](c1c2c(ccc1)cccc2)C)Cc1ccc<br />(cc1)OC)C)Cc1ccccc1
|
||||
| Target and Pathway | |||||
| Target(s) | Beta-secretase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020178) | ||||
| REF 2 | US patent application no. 8,269,019, Inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.